Skip to main content

CVS, Aetna execs confident that acquisition will pass antitrust scrutiny

CVS Health Corp.’s planned acquisition of Aetna Inc. will face tough antitrust scrutiny, but the limited overlap between the companies’ businesses should help bolster their case for the deal, experts said.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.